![Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumours and poor prognostic features—An exploratory analysis of placebo-controlled trials]()
Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumours and poor prognostic features—An exploratory analysis of placebo-controlled trialsColeman, Robert E.; Lipton, Allan; Costa, Luis; Cook, Richard J.; Lee, Ker-Ai; Saad, Fred; Brown, Janet E.; Terpos, Evangelos; Major, Pierre P.; Kohno, Norio; Smith, Matthew; Body, Jean-Jacques · Journal of Bone Oncology · 2013